If this product has an expiration or retest date, it will be shown on the Certificate of Analysis (COA, CofA). If there is no retest or expiration date listed on the product's COA, we do not have suitable stability data to determine a shelf life. For these products, the only date on the COA will be the release date; a retest, expiration, or use-by-date will not be displayed.
For all products, we recommend handling per defined conditions as printed in our product literature and website product descriptions. We recommend that products should be routinely inspected by customers to ensure they perform as expected.
For products without retest or expiration dates, our standard warranty of 1 year from the date of shipment is applicable.
For more information, please refer to the Product Dating Information document: https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/marketing/global/documents/418/501/product-dating-information-06-25-mk.pdf
G3632
Gentamicin sulfate salt
potency: ≥590 I.U. Gentamicin base per mg
Synonym(s):
GM Sulfate, Gentamicin C
Select a Size
| Size/SKU | Availability | Price |
|---|---|---|
250 mg | Available to ship TODAYfromMILWAUKEE | $56.50 |
1 g | Available to ship TODAYfromMILWAUKEE | $124.00 |
5 g | Available to ship TODAYfromMILWAUKEE | $410.00 |
10 g | Available to ship TODAYfromMILWAUKEE | $658.00 |
25 g | Available to ship TODAYfromMILWAUKEE | $1,310.00 |
100 g | Available to ship TODAYfromMILWAUKEE | Inquire |
About This Item
biological source
Micromonospora purpurea
Quality Segment
form
powder
potency
≥590 I.U. Gentamicin base per mg, ≥590 units/mg Gentamicin
storage condition
(Tightly closed. Dry. )
concentration
50 μg/mL in H2O (is the recommended working concentration for eukaryotic cell culture)
color
white to off-white
antibiotic activity spectrum
Gram-negative bacteria, Gram-positive bacteria, mycoplasma
application(s)
advanced drug delivery
mode of action
protein synthesis | interferes
storage temp.
2-8°C
SMILES string
O=S(O)(O)=O.O[C@]1(C)[C@@H]([C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@@](CC[C@H]3N)([C@@H](C)NC)[H])[C@@H](N)C[C@H]2N)OC1)NC.O[C@]4(C)[C@@H]([C@@H](O)[C@@H](O[C@@H]5[C@@H](O)[C@H](O[C@H]6O[C@@](CC[C@H]6N)([C@@H](C)N)[H])[C@@H](N)C[C@H]5N)OC4)NC.O[
InChI
1S/C21H43N5O7.C20H41N5O7.C19H39N5O7.H2O4S/c1-9(25-3)13-6-5-10(22)19(31-13)32-16-11(23)7-12(24)17(14(16)27)33-20-15(28)18(26-4)21(2,29)8-30-20;1-8(21)12-5-4-9(22)18(30-12)31-15-10(23)6-11(24)16(13(15)26)32-19-14(27)17(25-3)20(2,28)7-29-19;1-19(27)7-28-18(13(26)16(19)24-2)31-15-11(23)5-10(22)14(12(15)25)30-17-9(21)4-3-8(6-20)29-17;1-5(2,3)4/h9-20,25-29H,5-8,22-24H2,1-4H3;8-19,25-28H,4-7,21-24H2,1-3H3;8-18,24-27H,3-7,20-23H2,1-2H3;(H2,1,2,3,4)/t9-,10-,11+,12-,13+,14+,15-,16-,17+,18-,19-,20-,21+;8-,9-,10+,11-,12+,13+,14-,15-,16+,17-,18-,19-,20+;8-,9+,10-,11+,12-,13+,14+,15-,16+,17+,18+,19-;/m110./s1
InChI key
RDEIXVOBVLKYNT-HDZPSJEVSA-N
General description
Application
Biochem/physiol Actions
Antimicrobial spectrum: Includes Gram-negative and Gram-positive bacteria, including strains resistant to tetracycline, chloramphenicol, kanamycin and colistin, particularly strains of Pseudomonas, Proteus, Staphylococcus and Streptococcus.
Features and Benefits
Preparation Note
Other Notes
1 of 1
This Item | |||
|---|---|---|---|
| description potency: ≥590 I.U. Gentamicin base per mg | description powder, BioReagent, suitable for cell culture | description Pharmaceutical Secondary Standard; Certified Reference Material | description British Pharmacopoeia (BP) Reference Standard |
| mode of action protein synthesis | interferes | mode of action protein synthesis | interferes | mode of action - | mode of action - |
| antibiotic activity spectrum mycoplasma, Gram-negative bacteria, Gram-positive bacteria | antibiotic activity spectrum mycoplasma, Gram-negative bacteria, Gram-positive bacteria | antibiotic activity spectrum - | antibiotic activity spectrum - |
| Quality Level 200 | Quality Level 200 | Quality Level 300 | Quality Level - |
| form powder | form powder | form - | form powder |
| application(s) advanced drug delivery | application(s) - | application(s) pharmaceutical (small molecule) | application(s) pharmaceutical |
| concentration 50 μg/mL in H2O (is the recommended working concentration for eukaryotic cell culture) | concentration - | concentration - | concentration - |
Still not finding the right product?
Explore all of our products under Gentamicin sulfate salt
Signal Word
Warning
Hazard Codes
Precautionary Statements
Hazard Classifications
Skin Sens. 1
Storage Class
11 - Combustible Solids
WGK
WGK 2
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
PPE (personal protective equipment)
dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
-
How can I determine the shelf life / expiration / retest date of this product?
1 answer-
Helpful?
-
-
How is shipping temperature determined? And how is it related to the product storage temperature?
1 answer-
Products may be shipped at a different temperature than the recommended long-term storage temperature. If the product quality is sensitive to short-term exposure to conditions other than the recommended long-term storage, it will be shipped on wet or dry-ice. If the product quality is NOT affected by short-term exposure to conditions other than the recommended long-term storage, it will be shipped at ambient temperature. As shipping routes are configured for minimum transit times, shipping at ambient temperature helps control shipping costs for our customers. For more information, please refer to the Storage and Transport Conditions document: https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/marketing/global/documents/316/622/storage-transport-conditions-mk.pdf
Helpful?
-
-
G3632の1g当たりの力価について教えて頂きたいです。
1 answer-
Product G3632 potency specification is ≥590 units/mg or I.U. Gentamicin base per mg. For lot specific results, please review the Certificate of Analysis for that lot.
Helpful?
-
-
Regarding the MQ Levels, can you please clarify the difference between "enhanced control" and increased control"
1 answer-
The difference between enhanced control and increased control, in reference to the M-Clarity program, is essentially a matter of degrees. The MQ 100 level products are intended for use in basic research and minimum control is applied to areas such as sourcing, testing method, and available documentation. With increasing MQ levels more rigid controls and guidelines are put in place for these products. The MQ 200 products have an 'increased' level of control while MQ 300 level products having 'enhanced' level of control. Considering the breadth of products offered the specific controls are subject to the nature of the product.
The link below offers a line-by-line listing of the various discriminating attributes that are considered 'controls'.
https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/marketing/global/documents/323/519/M-Clarity_attributes_table_ms.pdfHelpful?
-